Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.

Abdelgawad, Ibrahim Y; Grant, Marianne K O; Zordoky, Beshay N

Abdelgawad, Ibrahim Y; Grant, Marianne K O; Zordoky, Beshay N.

Affiliation

Abdelgawad IY; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. abdel217@umn.edu.
Grant MKO; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. grant032@umn.edu.
Zordoky BN; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. zordo001@umn.edu.

Nutrients ; 11(3)2019 Mar 14.

Article in En | MEDLINE | ID: mdl-30875799

Subject(s)

Antineoplastic Agents; Cardiotonic Agents; Cardiovascular Diseases; Neoplasms; Resveratrol; Animals; Cardiovascular Diseases/complications; Cardiovascular Diseases/drug therapy; Cell Line, Tumor; Humans; Medical Oncology; Mice; Neoplasms/complications; Neoplasms/drug therapy

Key words

anthracycline; cancer; cardio-oncology; cardiotoxicity; cardiovascular; resveratrol

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiotonic Agents / Cardiovascular Diseases / Resveratrol / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Nutrients Year: 2019 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google